Terug
29
98
Ook genoteerd als
QABSY
OTC
Dagbereik
€ 6,10
€ 6,35
52-Weeksbereik
€ 4,49
€ 7,80
Volume
1
50D / 200D Gem.
€ 6,87
/
€ 6,87
Vorige Slotkoers
€ 6,10
Koershistorie
Financiële Trends
Sectorvergelijking
vs Industrials sector mediaan (889 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 5,8 | 9,1 |
| P/B | 11,9 | 2,0 |
| ROE % | 300,8 | 12,9 |
| Net Margin % | 6,9 | 7,9 |
| Rev Growth 5Y % | 40,9 | 8,6 |
| D/E | 10,2 | 0,6 |
Belangrijkste Punten
Revenue grew 40,93% annually over 5 years — strong growth
Earnings grew 27,89% over the past year
ROE of 300,84% indicates high profitability
Debt/Equity of 10,23 — high leverage
Generating 448,00M in free cash flow
P/E of 5,75 — trading at a low valuation
Groei
Revenue Growth (5Y)
40,93%
Revenue (1Y)8,29%
Earnings (1Y)27,89%
FCF Growth (3Y)-57,59%
Kwaliteit
Return on Equity
300,84%
ROIC17,53%
Net Margin6,86%
Op. Margin8,72%
Veiligheid
Debt / Equity
10,23
Current Ratio0,36
Interest Coverage7,79
Waardering
P/E Ratio
5,75
P/B Ratio11,86
EV/EBITDA7,34
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,29% | Revenue Growth (3Y) | 8,69% |
| Earnings Growth (1Y) | 27,89% | Earnings Growth (3Y) | -4,12% |
| Revenue Growth (5Y) | 40,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 23,41B | Net Income (TTM) | 1,61B |
| ROE | 300,84% | ROA | 6,87% |
| Gross Margin | 54,51% | Operating Margin | 8,72% |
| Net Margin | 6,86% | Free Cash Flow (TTM) | 448,00M |
| ROIC | 17,53% | FCF Growth (3Y) | -57,59% |
| Safety | |||
| Debt / Equity | 10,23 | Current Ratio | 0,36 |
| Interest Coverage | 7,79 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 5,75 | P/B Ratio | 11,86 |
| P/S Ratio | 0,39 | PEG Ratio | 0,23 |
| EV/EBITDA | 7,34 | Dividend Yield | 0,03% |
| Market Cap | 9,23B | Enterprise Value | 14,97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 23,41B | 21,62B | 19,82B | 9,11B | 5,93B |
| Net Income | 1,61B | 1,26B | 1,75B | -860,00M | -1,73B |
| EPS (Diluted) | 1,04 | 0,75 | 0,93 | -0,46 | -0,92 |
| Gross Profit | 12,76B | 11,46B | 7,00B | 1,91B | 1,57B |
| Operating Income | 2,04B | 1,87B | 6,75B | 1,79B | 1,50B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 23,36B | 20,56B | 20,35B | 19,65B | 17,88B |
| Total Liabilities | 22,57B | 20,27B | 20,34B | 19,84B | 17,36B |
| Shareholders' Equity | 778,00M | 289,00M | 5,00M | -197,00M | 513,00M |
| Total Debt | 7,96B | 6,59B | 6,73B | 7,23B | 8,23B |
| Cash & Equivalents | 2,21B | 1,72B | 3,17B | 3,34B | 2,22B |
| Current Assets | 4,52B | 3,98B | 5,11B | 5,63B | 3,43B |
| Current Liabilities | 12,72B | 11,74B | 12,10B | 10,56B | 7,60B |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#369 of 612
#4 of 655
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026